HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oriana Simonetti Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

10/2021Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model.
10/2020Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma.
4/2015Clinical and prognostic significance of survivin, AKT and VEGF in primary mucosal oral melanoma.
11/2002Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oriana Simonetti Research Topics

Disease

15Infections
02/2022 - 08/2013
10Wounds and Injuries (Trauma)
11/2021 - 01/2008
7Wound Infection (Wound Infections)
10/2021 - 01/2008
5Neoplasms (Cancer)
04/2022 - 11/2002
4Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 01/2015
4Melanoma (Melanoma, Malignant)
04/2022 - 11/2002
4Neoplasm Metastasis (Metastasis)
04/2022 - 03/2015
4Atopic Dermatitis (Atopic Eczema)
01/2022 - 02/2017
4Hidradenitis Suppurativa
01/2022 - 11/2020
4Sepsis (Septicemia)
11/2021 - 01/2016
3Skin Diseases (Skin Disease)
11/2021 - 01/2020
3COVID-19
06/2021 - 11/2020
3Surgical Wound
12/2019 - 04/2008
3Burns
01/2017 - 01/2012
3Staphylococcal Infections
01/2016 - 06/2008
2Hypersensitivity (Allergy)
06/2021 - 04/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2018 - 03/2015
2Cicatrix (Scar)
01/2017 - 01/2015
1Pneumonia (Pneumonitis)
02/2022
1Urinary Tract Infections (Urinary Tract Infection)
02/2022
1Pain (Aches)
01/2022
1Nasopharyngitis
11/2021
1Headache (Headaches)
11/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2021
1Staphylococcal Skin Infections
11/2021
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
10/2021
1Cross Infection (Nosocomial Infection)
08/2021
1Asthma (Bronchial Asthma)
04/2021
1Chronic Urticaria
04/2021
1Cutaneous Malignant Melanoma
10/2020
1Connective Tissue Nevus
03/2020
1Carcinogenesis
03/2018
1Squamous Cell Carcinoma of Head and Neck
03/2018
1Carcinoma in Situ
03/2018

Drug/Important Bio-Agent (IBA)

8Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2008
5Tigecycline (Tygacil)FDA Link
01/2018 - 01/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 11/2002
4TeicoplaninIBA
12/2016 - 01/2008
3DaptomycinFDA Link
12/2017 - 12/2016
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2013 - 11/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2022 - 02/2017
2CollagenIBA
10/2021 - 06/2013
2VaccinesIBA
06/2021 - 04/2021
2Biological ProductsIBA
04/2021 - 11/2019
2Messenger RNA (mRNA)IBA
04/2021 - 10/2020
2dalbavancinIBA
01/2021 - 01/2020
2Biomarkers (Surrogate Marker)IBA
10/2020 - 01/2020
2Pharmaceutical PreparationsIBA
11/2019 - 01/2016
2pexigananIBA
01/2018 - 01/2016
2CopperIBA
01/2017 - 01/2012
2Colistin (Coly-Mycin)FDA Link
12/2016 - 01/2016
1TetraspaninsIBA
04/2022
1ceftazidime drug combination avibactamIBA
02/2022
1CephalosporinaseIBA
02/2022
1dupilumabIBA
01/2022
1Clindamycin (Cleocin)FDA LinkGeneric
01/2022
1resorcinol (resorcin)IBA
01/2022
1Janus Kinase InhibitorsIBA
11/2021
1baricitinibIBA
11/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2021
1Virulence Factors (Pathogenicity Factors)IBA
11/2021
1BerberineIBA
11/2021
1CathelicidinsIBA
10/2021
1Attenuated VaccinesIBA
10/2021
1CeftarolineFDA Link
08/2021
1Cephalosporins (Cephalosporin Antibiotics)IBA
08/2021
1homocysteine-thiolactone-nicotinamide (ST 22)IBA
08/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021
12019-nCoV Vaccine mRNA-1273IBA
04/2021
1BNT162 VaccineIBA
04/2021
1Excipients (Suspending Agents)IBA
04/2021
1COVID-19 VaccinesIBA
04/2021
1Omalizumab (Xolair)FDA Link
04/2021
1Interleukin-12 (IL 12)IBA
04/2021
1Interleukin-17 (Interleukin 17)IBA
04/2021
1Interleukin-23 (Interleukin 23)IBA
04/2021
1Semaphorins (Semaphorin)IBA
10/2020
1Semaphorin-3AIBA
10/2020
1trans-crotonin (CTN)IBA
03/2020
1AntioxidantsIBA
01/2020
1Oxidants (Oxidizing Agents)IBA
01/2020
1Peroxidase (Myeloperoxidase)IBA
01/2020
1Lipoproteins (Lipoprotein)IBA
01/2020
1VancomycinFDA LinkGeneric
01/2020
1Aryldialkylphosphatase (Paraoxonase)IBA
01/2020
1protegrin-1IBA
12/2019
1Anti-Infective Agents (Microbicides)IBA
12/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2019
1Monoclonal AntibodiesIBA
11/2019
1Adalimumab (Humira)FDA Link
11/2019
1Cell Adhesion MoleculesIBA
03/2018
1CEACAM1 ProteinIBA
03/2018

Therapy/Procedure

9Therapeutics
08/2022 - 06/2008
2Phototherapy (Light Therapy)
08/2022 - 11/2010
1Artificial Respiration (Mechanical Ventilation)
02/2022
1Organ Transplantation
02/2022
1Solid-State Lasers
01/2022
1Biological Therapy
04/2021
1Contraindications
04/2021
1Immunomodulation
11/2020